Evidence map›Paper›PMID 29216905›Full record

ArticleParasites & vectors2017

Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India.

Sarah Jervis, Lloyd A C Chapman, Shweta Dwivedi, Morchan Karthick, Aritra Das, Epke A Le Rutte, Orin Courtenay, Graham F Medley, Indranath Banerjee, Tanmay Mahapatra and 3 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. How I Approach Leishmaniasis: Diagnosis and Treatment in the United States.Journal of the Pediatric Infectious Diseases Society · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sarah JervisSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. sarahjervis99@gmail.com.
Lloyd A C ChapmanSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. L.Chapman.1@warwick.ac.uk.
Shweta DwivediCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Morchan KarthickCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Aritra DasCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Epke A Le RutteDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000, CA, Rotterdam, The Netherlands.
Orin CourtenaySchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK.
Graham F MedleyLondon School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Indranath BanerjeeCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Tanmay MahapatraCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Indrajit ChaudhuriCARE India Solutions for Sustainable Development, Patna, Bihar, India.
Sridhar SrikantiahCARE India Solutions for Sustainable Development, Patna, Bihar, India.
T Déirdre HollingsworthSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK.

Funding

Bill and Melinda Gates Foundation OPP1053230
6 · The paper itself

Abstract

backgroundVisceral leishmaniasis (VL) has been targeted by the WHO for elimination as a public health problem (< 1 case/10,000 people/year) in the Indian sub-continent (ISC) by 2020. Bihar State in India, which accounts for the majority of cases in the ISC, remains a major target for this elimination effort. However, there is considerable spatial, temporal and sub-population variation in occurrence of the disease and the pathway to care, which is largely unexplored and a threat to achieving the target.

methodsData from 6081 suspected VL patients who reported being clinically diagnosed during 2012-2013 across eight districts in Bihar were analysed. Graphical comparisons and Chi-square tests were used to determine differences in the burden of identified cases by season, district, age and sex. Log-linear regression models were fitted to onset (of symptoms)-to-diagnosis and onset-to-treatment waiting times to estimate their associations with age, sex, district and various socio-economic factors (SEFs). Logistic regression models were used to identify factors associated with mortality.

resultsComparisons of VL caseloads suggested an annual cycle peaking in January-March. A 17-fold variation in the burden of identified cases across districts and under-representation of young children (0-5 years) relative to age-specific populations in Bihar were observed. Women accounted for a significantly lower proportion of the reported cases than men (41 vs 59%, P < 0.0001). Age, district of residence, house wall materials, caste, treatment cost, travelling for diagnosis and the number of treatments for symptoms before diagnosis were identified as correlates of waiting times. Mortality was associated with age, district of residence, onset-to-treatment waiting time, treatment duration, cattle ownership and cost of diagnosis.

conclusionsThe distribution of VL in Bihar is highly heterogeneous, and reported caseloads and associated mortality vary significantly across different districts, posing different challenges to the elimination campaign. Socio-economic factors are important correlates of these differences, suggesting that elimination will require tailoring to population and sub-population circumstances.

Indexed as

Age FactorsHumansIndiaLeishmaniasis, VisceralRisk AssessmentSeasonsSex FactorsSocioeconomic FactorsTopography, MedicalBiharCase burdenIndiaMortalityOnset-to-diagnosis timeOnset-to-treatment timePathway to careStatistical analysisVisceral leishmaniasis

Identifiers

PMID29216905
PMCPMC5719561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.